{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:56:52Z","timestamp":1793055412980,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["mgmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.ymgme.2013.03.016","type":"journal-article","created":{"date-parts":[[2013,4,4]],"date-time":"2013-04-04T01:21:21Z","timestamp":1365038481000},"page":"174-178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Enzyme replacement therapy and fatigue in adults with Pompe disease"],"prefix":"10.1016","volume":"109","author":[{"given":"Deniz","family":"G\u00fcng\u00f6r","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juna M.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Brusse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle E.","family":"Kruijshaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim C.J.","family":"Hop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magda","family":"Murawska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda E.M.","family":"van den Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold J.J.","family":"Reuser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter A.","family":"van Doorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marloes L.C.","family":"Hagemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Plug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ans T.","family":"van der Ploeg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2013.03.016_bb0005","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s00018-009-0184-2","article-title":"Fatigue in neuromuscular disorders: focus on Guillain\u2013Barre syndrome and Pompe disease","volume":"67","author":"de Vries","year":"2010","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.ymgme.2013.03.016_bb0010","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0140-6736(04)15794-2","article-title":"Fatigue in neurological disorders","volume":"363","author":"Chaudhuri","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2013.03.016_bb0015","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/brain\/awh384","article-title":"Clinical manifestation and natural course of late-onset Pompe's disease in 54 Dutch patients","volume":"128","author":"Hagemans","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.ymgme.2013.03.016_bb0020","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.nmd.2010.11.016","article-title":"A case of adult Pompe disease presenting with severe fatigue and selective involvement of type 1 muscle fibers","volume":"21","author":"van den Berg","year":"2011","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymgme.2013.03.016_bb0025","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s00415-006-0434-2","article-title":"Fatigue: an important feature of late-onset Pompe disease","volume":"254","author":"Hagemans","year":"2007","journal-title":"J. Neurol."},{"key":"10.1016\/j.ymgme.2013.03.016_bb0030","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/S0140-6736(08)61555-X","article-title":"Pompe's disease","volume":"372","author":"van der Ploeg","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2013.03.016_bb0035","series-title":"Myology","article-title":"Acid maltase deficiency","author":"Engel","year":"2004"},{"key":"10.1016\/j.ymgme.2013.03.016_bb0040","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1212\/01.WNL.0000158682.85052.C0","article-title":"Respiratory failure in Pompe disease: treatment with noninvasive ventilation","volume":"64","author":"Mellies","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2013.03.016_bb0045","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa0909859","article-title":"A randomized study of alglucosidase alfa in late-onset Pompe's disease","volume":"362","author":"van der Ploeg","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2013.03.016_bb0050","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1007\/s00415-011-6293-5","article-title":"Observational clinical study in juvenile\u2013adult glycogenosis type 2 patients undergoing enzyme replacement therapy for up to 4years","volume":"259","author":"Angelini","year":"2012","journal-title":"J. Neurol."},{"key":"10.1016\/j.ymgme.2013.03.016_bb0055","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00415-009-5275-3","article-title":"Enzyme replacement therapy with alglucosidase alfa in 44 patients with late-onset glycogen storage disease type 2: 12-month results of an observational clinical trial","volume":"257","author":"Strothotte","year":"2010","journal-title":"J. Neurol."},{"key":"10.1016\/j.ymgme.2013.03.016_bb0060","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s10545-010-9201-8","article-title":"Long-term observational, non-randomized study of enzyme replacement therapy in late-onset glycogenosis type II","volume":"33","author":"Bembi","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2013.03.016_bb0065","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s00415-012-6636-x","article-title":"Enzyme replacement therapy in late-onset Pompe disease: a systematic literature review","volume":"260","author":"Toscano","year":"2013","journal-title":"J. Neurol."},{"key":"10.1016\/j.ymgme.2013.03.016_bb0070","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.nmd.2008.04.009","article-title":"Eight years experience with enzyme replacement therapy in two children and one adult with Pompe disease","volume":"18","author":"van Capelle","year":"2008","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymgme.2013.03.016_bb0075","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.clineuro.2010.12.005","article-title":"Adult Pompe disease: clinical manifestations and outcome of the first Greek patients receiving enzyme replacement therapy","volume":"113","author":"Papadimas","year":"2011","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.ymgme.2013.03.016_bb0165","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.nmd.2011.04.001","article-title":"Recombinant human acid alpha-glucosidase (rhGAA) in adult patients with severe respiratory failure due to Pompe disease","volume":"21","author":"Orlikowski","year":"2011","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymgme.2013.03.016_bb0080","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/archneur.1989.00520460115022","article-title":"The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus","volume":"46","author":"Krupp","year":"1989","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ymgme.2013.03.016_bb0085","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1212\/WNL.53.8.1648","article-title":"Fatigue in immune-mediated polyneuropathies. European Inflammatory Neuropathy Cause and Treatment (INCAT) Group","volume":"53","author":"Merkies","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2013.03.016_bb0090","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0022-3999(03)00371-4","article-title":"The assessment of fatigue: a practical guide for clinicians and researchers","volume":"56","author":"Dittner","year":"2004","journal-title":"J. Psychosom. Res."},{"key":"10.1016\/j.ymgme.2013.03.016_bb0095","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s00415-006-0163-6","article-title":"Residual fatigue is independent of antecedent events and disease severity in Guillain\u2013Barre syndrome","volume":"253","author":"Garssen","year":"2006","journal-title":"J. Neurol."},{"key":"10.1016\/j.ymgme.2013.03.016_bb0100","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ymgme.2011.06.012","article-title":"Rate of progression and predictive factors for pulmonary outcome in children and adults with Pompe disease","volume":"104","author":"van der Beek","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2013.03.016_bb0105","series-title":"Aids to Examination of the Peripheral Nervous System","author":"Medical Research Council","year":"1976"},{"key":"10.1016\/j.ymgme.2013.03.016_bb0110","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1750-1172-7-73","article-title":"Effect of enzyme therapy and prognostic factors in 69 adults with Pompe disease: an open-label single-center study","volume":"7","author":"de Vries","year":"2012","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2013.03.016_bb0115","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The Hospital Anxiety and Depression Scale","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.ymgme.2013.03.016_bb0120","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0022-3999(01)00296-3","article-title":"The validity of the Hospital Anxiety and Depression Scale. An updated literature review","volume":"52","author":"Bjelland","year":"2002","journal-title":"J. Psychosom. Res."},{"key":"10.1016\/j.ymgme.2013.03.016_bb0125","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ymgme.2012.08.019","article-title":"Fat and carbohydrate metabolism during exercise in late-onset Pompe disease","volume":"107","author":"Preisler","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2013.03.016_bb0130","series-title":"Exercise Physiology","first-page":"314","article-title":"Skeletal muscle: structure and function","author":"McArdle","year":"1996"},{"key":"10.1016\/j.ymgme.2013.03.016_bb0135","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.acn.2005.04.002","article-title":"An examination of four models predicting fatigue in multiple sclerosis","volume":"20","author":"Strober","year":"2005","journal-title":"Arch. Clin. Neuropsychol."},{"key":"10.1016\/j.ymgme.2013.03.016_bb0140","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/01.psy.0000124757.10167.b1","article-title":"Temporal relations between unexplained fatigue and depression: longitudinal data from an international study in primary care","volume":"66","author":"Skapinakis","year":"2004","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.ymgme.2013.03.016_bb0145","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1212\/WNL.0b013e31821043a4","article-title":"Fatigue in spinocerebellar ataxia: patient self-assessment of an early and disabling symptom","volume":"76","author":"Brusse","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2013.03.016_bb0150","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1136\/jnnp.2004.054635","article-title":"Depression in multiple sclerosis: a review","volume":"76","author":"Siegert","year":"2005","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ymgme.2013.03.016_bb0155","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1136\/jnnp.2004.046227","article-title":"Amantadine for treatment of fatigue in Guillain\u2013Barre syndrome: a randomised, double blind, placebo controlled, crossover trial","volume":"77","author":"Garssen","year":"2006","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ymgme.2013.03.016_bb0160","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2340\/16501977-0007","article-title":"Analysing the favourable effects of physical exercise: relationships between physical fitness, fatigue and functioning in Guillain\u2013Barre syndrome and chronic inflammatory demyelinating polyneuropathy","volume":"39","author":"Bussmann","year":"2007","journal-title":"J. Rehabil. Med."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719213001054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719213001054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,17]],"date-time":"2018-10-17T02:50:57Z","timestamp":1539744657000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719213001054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S1096719213001054"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2013.03.016","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enzyme replacement therapy and fatigue in adults with Pompe disease","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2013.03.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}